-
Your selected country is
United States
- Change country/language
-
Reagents
- Flow Cytometry Reagents
-
Western Blotting and Molecular Reagents
- Immunoassay Reagents
-
Single-Cell Multiomics Reagents
- BD® OMICS-Guard Sample Preservation Buffer
- BD® AbSeq Assay
- BD® OMICS-One Immune Profiler Protein Panel
- BD® Single-Cell Multiplexing Kit
- BD Rhapsody™ ATAC-Seq Assays
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ Accessory Kits
-
Functional Assays
-
Microscopy and Imaging Reagents
-
Cell Preparation and Separation Reagents
-
- BD® OMICS-Guard Sample Preservation Buffer
- BD® AbSeq Assay
- BD® OMICS-One Immune Profiler Protein Panel
- BD® Single-Cell Multiplexing Kit
- BD Rhapsody™ ATAC-Seq Assays
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ Accessory Kits
- United States (English)
- Change country/language
Old Browser
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
Multiparameter Flow Cytometric Analysis of CD59 Expression on Human Leucocytes Left Panel: CD59 expression on different leucocyte populations. Whole blood was stained with either Alexa Fluor™ 647 Mouse IgG2a, κ Isotype Control (Cat. No. 565357; Top Plot) or Alexa Fluor™ 647 Mouse Anti-Human CD59 antibody (Cat. No. 568270; Bottom Plot Plot). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). The pseudocolor density plot showing the correlated expression of CD59 [or Ig isotype control] versus side light-scatter signals (SSC) was derived from gated events with the forward and side-light scatter characteristics of viable leucocyte populations. Right Panel: CD59 expression on different lymphocyte subpopulations. Whole blood was similarly stained with BD Horizon™ BUV395 Mouse Anti-Human CD3 (Cat. No. 563546/563548) and PE Mouse Anti-Human NCAM-1 (CD56) (Cat. No. 563238) antibodies and with either Alexa Fluor™ 647 Mouse IgG2a, κ Isotype Control (Top Plots) or Alexa Fluor™ 647 Mouse Anti-Human CD59 antibody (Bottom Plots). Erythrocytes were similarly lysed. The pseudocolor density plots showing the correlated expression of CD59 [or Ig isotype control] versus CD3 (Left Plots) or versus CD56 (Right Plots) were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry and data analysis were performed using a LSRFortessa™ X-20 Cell Analyzer System and FlowJo® software.
BD Pharmingen™ Alexa Fluor™ 647 Mouse Anti-Human CD59
Regulatory Status Legend
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Preparation And Storage
Recommended Assay Procedures
BD® CompBeads can be used as surrogates to assess fluorescence spillover (Compensation). When fluorochrome conjugated antibodies are bound to CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cells and CompBead to ensure that BD® CompBeads are appropriate for your specific cellular application.
Product Notices
- Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
- Alexa Fluor® 647 fluorochrome emission is collected at the same instrument settings as for allophycocyanin (APC).
- Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
- For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.
- This product is provided under an intellectual property license between Life Technologies Corporation and BD Businesses. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The buyer cannot sell or otherwise transfer (a) this product (b) its components or (c) materials made using this product or its components to a third party or otherwise use this product or its components or materials made using this product or its components for Commercial Purposes. Commercial Purposes means any activity by a party for consideration and may include, but is not limited to: (1) use of the product or its components in manufacturing; (2) use of the product or its components to provide a service, information, or data; (3) use of the product or its components for therapeutic, diagnostic or prophylactic purposes; or (4) resale of the product or its components, whether or not such product or its components are resold for use in research. For information on purchasing a license to this product for any other use, contact Life Technologies Corporation, Cell Analysis Business Unit Business Development, 29851 Willow Creek Road, Eugene, OR 97402, USA, Tel: (541) 465-8300. Fax: (541) 335-0504.
- Please refer to http://regdocs.bd.com to access safety data sheets (SDS).
- Alexa Fluor™ is a trademark of Life Technologies Corporation.
- This reagent has been pre-diluted for use at the recommended Volume per Test. We typically use 1 × 10^6 cells in a 100-µl experimental sample (a test).
- An isotype control should be used at the same concentration as the antibody of interest.
- Source of all serum proteins is from USDA inspected abattoirs located in the United States.
- For U.S. patents that may apply, see bd.com/patents.
Companion Products
The MEM-43 monoclonal antibody specifically recognizes CD59 which is also known as the MEM43 antigen (MEM43). This 19 kDa glycosylphosphatidylinositol (GPI)-anchored glycoprotein is expressed on all hematopoietic and non-hematopoietic cells. Because of its interaction with activated complement products, CD59 has been termed Membrane Attack Complex Inhibition Factor (MACIF), Homologus Restriction Factor (HRF20), Membrane Inhibitor of Reactive Lysis (MIRL), and Protectin. CD59 inhibits complement-mediated cellular lysis by binding to C8 and C9, thereby blocking the final assembly of the complement Membrane Attack Complex (MAC). CD59 also participates in spontaneous T-cell/erythrocyte adhesion, interacts with CD2, and plays a role in T-cell activation.
Development References (7)
-
Bodian DL, Davis SJ, Morgan BP, Rushmere NK. Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59.. J Exp Med. 1997; 185(3):507-16. (Clone-specific). View Reference
-
Forsberg UH, Bazil V, Stefanová I, Schröder J. Gene for human CD59 (likely Ly-6 homologue) is located on the short arm of chromosome 11.. Immunogenetics. 1989; 30(3):188-93. (Biology). View Reference
-
Horejsí V, Hilgert I, Kristofová H, Bazil V, Bukovský A, Kulhánková J. Monoclonal antibodies against human leucocyte antigens. I. Antibodies against beta-2-microglobulin, immunoglobulin kappa light chains, HLA-DR-like antigens, T8 antigen, T1 antigen, a monocyte antigen, and a pan-leucocyte antigen.. Folia Biol (Praha). 1986; 32(1):12-25. (Immunogen: Flow cytometry). View Reference
-
Meri S, Morgan BP, Davies A, et al. Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.. Immunology. 1990; 71(1):1-9. (Clone-specific). View Reference
-
Omidvar N, Wang EC, Brennan P, Longhi MP, Smith RA, Morgan BP. Expression of glycosylphosphatidylinositol-anchored CD59 on target cells enhances human NK cell-mediated cytotoxicity.. J Immunol. 2006; 176(5):2915-23. (Clone-specific: Flow cytometry, Functional assay). View Reference
-
Sutherland DR, Illingworth A, Marinov I, et al. ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 2 - reagent selection and assay optimization for high-sensitivity testing.. Cytometry B Clin Cytom. 2018; 94(1):23-48. (Clone-specific: Flow cytometry). View Reference
-
Sutherland DR, Keeney M, Illingworth A. Practical guidelines for the high-sensitivity detection and monitoring of paroxysmal nocturnal hemoglobinuria clones by flow cytometry.. Cytometry B Clin Cytom. 2012; 82(4):195-208. (Clone-specific: Flow cytometry). View Reference
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.